Study wrapper · #704
Modulation of GABA- and Glycine-Activated Ionic Currents with Semax in Isolated Cerebral Neurons.
Editor's note
This concentration-clamp electrophysiology study in isolated rat neurons reported that 1 microM Semax increased GABA-activated currents in cerebellar Purkinje cells by about 147%, while 0.1 to 1 microM Semax reduced glycine-activated chloride currents in hippocampal neurons to 68% and 43% of control. Both effects developed slowly and were poorly reversible, hinting at involvement of intracellular second messengers rather than direct channel binding. This is fine-grained mechanistic in-vitro work supporting the idea that Semax modulates inhibitory neurotransmission in cell-type-specific ways. It informs mechanism only, with no bearing on clinical outcomes. These are preclinical findings; human data are needed before clinical conclusions can be drawn.
Plain-language abstract
GABA and glycine are two chemicals that calm nerve cells by letting chloride flow through channels. This lab study measured how Semax changes the electrical currents these chemicals produce in individual rat neurons. Semax roughly doubled the GABA-driven current in one cell type (cerebellar Purkinje cells) but cut the glycine-driven current in another (hippocampal neurons) by up to about half. Notably, these effects built up slowly and did not easily reverse, suggesting Semax works through internal cell-signaling steps rather than by directly plugging into the channels. The findings show Semax adjusts the brain's calming signals in ways that differ by cell type. This is detailed laboratory work on isolated cells aimed at understanding mechanism; it does not test any effect in animals or people.